August 12, 2026

First patient in Skylark Bio’s Phase I/II trial receives SKY-GJB2 gene therapy

​Skylark Bio has dosed the first patient in its SONIX Phase I/II clinical trial assessing SKY-GJB2 as a potential gene...

August 12, 2026

Alfasigma signs agreement to acquire Nordic Group

​Alfasigma is to buy Nordic Group, which aims to strengthen its speciality care business and expand its reach in Europe,...

August 11, 2026

AbCellera reports favourable Phase II data for ABCL635

​AbCellera has reported encouraging top-line data from the Phase II segment of its Phase I/II study assessing ABCL635.The post AbCellera...

August 11, 2026

Acarix secures approval in UAE for CADScor system

​Acarix has secured regulatory approval for its CADScor system in the UAE, a step that paves the way for the...

August 11, 2026

Jazz Pharmaceuticals to acquire Actio Biosciences for $820m upfront 

​Jazz Pharmaceuticals is to acquire Actio Biosciences in a deal that includes an $820m upfront payment and up to $500m...

August 10, 2026

RenovoRx reports RenovoCath’s first clinical use in sarcoma

​RenovoRx has reported the first commercial clinical use of its RenovoCath device for the treatment of a sarcoma patient.The post...

August 10, 2026

Neurocrine begins Phase I trial of NBIP-‘1968 triple agonist for obesity

​Neurocrine Biosciences has initiated a Phase I clinical study to evaluate NBIP-'1968 as a potential treatment for obesity.The post Neurocrine...

August 10, 2026

Energenesis and Taiwan Tanabe to develop ENERGI-F703DFU for DFUs

​Energenesis has signed a development agreement with Taiwan Tanabe for its investigational topical drug ENERGI-F703DFU to treat DFUs.The post Energenesis...

August 7, 2026

Co-Diagnostics files FDA 510(k) for flu and RSV PCR test

​Co-Diagnostics has filed a Dual 510(k) premarket notification with the FDA for its Co-Dx PCR Flu A/B & RSV upper...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.